Business Development
As a leading biopharma company, partnering is a key priority for us and plays a critical role in our strategy. We seek to combine external innovative science and technologies with our internal capabilities and expertise to transform patients’ lives through science. Partnerships and collaborations are essential to evolving our portfolio and driving our long-term sustainability.
We have a distinct and decisive approach to partnering that leverages the best of Bristol Myers Squibb and the best of our partners to speed transformational medicines to patients. We strive to be a partner of choice and establish a creative and customized approach for each agreement.
Our areas of interest
External innovation and partnering are critical drivers of our strategy and have brought significant commercial success and pipeline growth.
